MedPath

JNTX-102

Generic Name
JNTX-102
Clinical Trials
Related News

Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis

Phase 4
Completed
Conditions
Hepatic Encephalopathy
Interventions
First Posted Date
2009-04-23
Last Posted Date
2012-12-17
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
56
Registration Number
NCT00886925
Locations
🇪🇸

Hospital de Sant Pau, Barcelona, Spain

🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Spain

🇪🇸

Parc Tauli, Sabadell, Barcelona, Spain

and more 1 locations

Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study

Phase 2
Conditions
Renal Impairment
All Cause Mortality
Interventions
First Posted Date
2009-02-27
Last Posted Date
2010-06-07
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
43
Registration Number
NCT00852800
Locations
🇧🇷

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation

Phase 4
Completed
Conditions
Renal Failure
Hepatic Encephalopathy
Hyponatremia
Sepsis
Gastrointestinal Bleeding
Interventions
Drug: Placebo
First Posted Date
2009-02-09
Last Posted Date
2016-08-18
Lead Sponsor
Hospital Clinic of Barcelona
Target Recruit Count
199
Registration Number
NCT00839358
Locations
🇪🇸

Hospital Clinic, Villarroel 170, Barcelona, Spain

AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis

Phase 2
Conditions
Systemic Sclerosis
Interventions
Drug: Hyperimmune caprine serum
First Posted Date
2008-10-08
Last Posted Date
2011-08-18
Lead Sponsor
Daval International Limited
Target Recruit Count
20
Registration Number
NCT00769028
Locations
🇬🇧

Centre for Rheumatology and Connective Tissue Diseases, Lower Ground Floor, Royal Free Hospital NHS Trust, Hampstead, London, United Kingdom

Early Albumin Resuscitation During Septic Shock

Phase 4
Completed
Conditions
Septic Shock
Interventions
Drug: saline
First Posted Date
2006-05-18
Last Posted Date
2011-04-06
Lead Sponsor
Laboratoire français de Fractionnement et de Biotechnologies
Target Recruit Count
794
Registration Number
NCT00327704
Locations
🇫🇷

Cochin Hospital, Paris, France

Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis

Phase 4
Completed
Conditions
Ascites
Cirrhosis
Interventions
Drug: Intravenous Saline Infusion (Albumin placebo)
Drug: Oral tablet (Midodrine placebo)
Drug: Saline injection (Octreotide LAR placebo)
Procedure: Large Volume Paracentesis
First Posted Date
2005-04-15
Last Posted Date
2014-03-06
Lead Sponsor
US Department of Veterans Affairs
Target Recruit Count
29
Registration Number
NCT00108355
Locations
🇺🇸

VA Connecticut Health Care System (West Haven), West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy